Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials.
Johnson S, Louie TJ, Gerding DN, Cornely OA, Chasan-Taber S, Fitts D, Gelone SP, Broom C, Davidson DM; Polymer Alternative for CDI Treatment (PACT) investigators. Johnson S, et al. Among authors: gelone sp. Clin Infect Dis. 2014 Aug 1;59(3):345-54. doi: 10.1093/cid/ciu313. Epub 2014 May 5. Clin Infect Dis. 2014. PMID: 24799326 Clinical Trial.
Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial.
File TM, Goldberg L, Das A, Sweeney C, Saviski J, Gelone SP, Seltzer E, Paukner S, Wicha WW, Talbot GH, Gasink LB. File TM, et al. Among authors: gelone sp. Clin Infect Dis. 2019 Nov 13;69(11):1856-1867. doi: 10.1093/cid/ciz090. Clin Infect Dis. 2019. PMID: 30722059 Free PMC article. Clinical Trial.
Improving Traditional Registrational Trial End Points: Development and Application of a Desirability of Outcome Ranking End Point for Complicated Urinary Tract Infection Clinical Trials.
Howard-Anderson J, Hamasaki T, Dai W, Collyar D, Rubin D, Nambiar S, Kinamon T, Hill C, Gelone SP, Mariano D, Baba T, Holland TL, Doernberg SB, Chambers HF, Fowler VG, Evans SR, Boucher HW. Howard-Anderson J, et al. Among authors: gelone sp. Clin Infect Dis. 2023 Feb 8;76(3):e1157-e1165. doi: 10.1093/cid/ciac692. Clin Infect Dis. 2023. PMID: 36031403 Free PMC article.
Reply to Tang and Lai.
File TM, Gelone SP, Schranz J, Alexander E. File TM, et al. Among authors: gelone sp. Clin Infect Dis. 2020 Sep 12;71(6):1583. doi: 10.1093/cid/ciz1174. Clin Infect Dis. 2020. PMID: 31822883 No abstract available.
Fluoroquinolones.
O'Donnell JA, Gelone SP. O'Donnell JA, et al. Among authors: gelone sp. Infect Dis Clin North Am. 2000 Jun;14(2):489-513, xi. doi: 10.1016/s0891-5520(05)70260-9. Infect Dis Clin North Am. 2000. PMID: 10829268 Review.
The newer fluoroquinolones.
O'Donnell JA, Gelone SP. O'Donnell JA, et al. Among authors: gelone sp. Infect Dis Clin North Am. 2004 Sep;18(3):691-716, x. doi: 10.1016/j.idc.2004.04.011. Infect Dis Clin North Am. 2004. PMID: 15308282 Review.
Paromomycin for nitroimidazole-resistant trichomonosis.
Nyirjesy P, Weitz MV, Gelone SP, Fekete T. Nyirjesy P, et al. Among authors: gelone sp. Lancet. 1995 Oct 21;346(8982):1110. doi: 10.1016/s0140-6736(95)91788-8. Lancet. 1995. PMID: 7564825 No abstract available.
36 results